Cytomx Therap
CTMX----
Cytomx Therap (CTMX)
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenv...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Cytomx Therap Analyst Rating
View MoreForecast & Rating
Jun 12, 2026Price forecast
$12.50270.92%
Forecast & RatingStrong buy
8analysts
- Strong buy62.50%
- Buy37.50%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jun 22 at 03:53 PM
CytomX Therapeutics doubles authorized common shares to 600 million
- Tip Ranks · Jun 5 at 04:08 PM
3 Best Cheap Stocks Under $10 to Buy Now, According to Analysts
- nasdaq · Jun 4 at 08:55 AM
CytomX Secures $37M Regeneron Pact; Analyst Sets Price Target At $11
- Pharmaceutical Technology · Jun 4 at 03:21 AM
Regeneron and CytomX extend cancer therapy partnership to $4bn deal
- Tip Ranks · May 26 at 04:22 AM
5 Healthcare Stocks Set to Join the Russell 3000
- Market Beat · May 13 at 07:08 AM
HC Wainwright Analysts Increase Earnings Estimates for CTMX
